Targacept says drug candidate worked as an asthma treatment, but fails as … – The Republic

Targacept says drug candidate worked as an asthma treatment, but fails as
The Republic
AP WINSTON-SALEM, NC — Shares of Targacept Inc. declined Tuesday after the company said its drug candidate TC-6987 worked as a treatment for asthma in a clinical trial, but failed as a treatment for diabetes. Targacept said asthma patients who were
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of MarketWatch (press release)
Asthma drug shows promise, diabetes study fails in Targacept phase 2 trialsMedCity News
Targacept reports mixed data from two trialsReuters
Bizjournals.com –FierceBiotech
all 25 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.